Syrma SGS Intrinsic Value
SYRMA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹224.82 | ₹179.86 - ₹269.78 | -70.0% | EPS: ₹13.76, Sector P/E: 12x |
| Book Value Method | asset | ₹149.88 | ₹134.89 - ₹164.87 | -80.0% | Book Value/Share: ₹102.53, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹224.82 | ₹202.34 - ₹247.30 | -70.0% | Revenue/Share: ₹259.55, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹299.76 | ₹269.78 - ₹329.74 | -60.0% | EBITDA: ₹496.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹299.76 | ₹239.81 - ₹359.71 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹224.82 | ₹202.34 - ₹247.30 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹224.82 | ₹202.34 - ₹247.30 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹374.70 | ₹337.23 - ₹412.17 | -50.0% | ROE: 14.5%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹224.82 | ₹202.34 - ₹247.30 | -70.0% | EPS: ₹13.76, BVPS: ₹102.53 |
Want to compare with current market value? Check SYRMA share price latest .
Valuation Comparison Chart
SYRMA Intrinsic Value Analysis
What is the intrinsic value of SYRMA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Syrma SGS (SYRMA) is ₹224.82 (median value). With the current market price of ₹749.40, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹149.88 to ₹374.70, indicating ₹149.88 - ₹374.70.
Is SYRMA undervalued or overvalued?
Based on our multi-method analysis, Syrma SGS (SYRMA) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 17.72 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 2.30 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 14.5% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 10.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.10x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Syrma SGS
Additional stock information and data for SYRMA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹177 Cr | ₹126 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-114 Cr | ₹-119 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-70 Cr | ₹-513 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-13 Cr | ₹-200 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹37 Cr | ₹-20 Cr | Positive Operating Cash Flow | 6/10 |